Cargando…
Comparison of clinically approved molecules on SARS-CoV-2 drug target proteins: a molecular docking study
The new type of coronavirus, SARS-CoV-2 has affected more than 22.6 million people worldwide. Since the first day the virus was spotted in Wuhan, China, numerous drug design studies have been conducted all over the globe. Most of these studies target the receptor-binding domain of spike protein of S...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Scientific and Technological Research Council of Turkey
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925319/ https://www.ncbi.nlm.nih.gov/pubmed/33679150 http://dx.doi.org/10.3906/kim-2008-35 |